FDA CDER Impact Story: Regulatory Science is Strengthening U.S. Drug Product Manufacturing - Drug Information Update

Continuous manufacturing is a quicker, more reliable way to make pharmaceuticals than the traditional “batch” process and can help reduce product and facility quality–related drug shortages. CDER supports and sponsors research related to implementation of continuous manufacturing, an uninterrupted process that involves online quality assurance monitoring and has fewer opportunities for human error. To learn more, please visit: CDER Impact Story.